Funding for the MCW Ocular Gene Therapy Laboratory
Active Grant Support for the Ocular Gene Therapy Laboratory
National Eye Institute Research Project Grant (R01EY032478) ‘Development of an IOP-lowering gene therapy treatment for glaucoma’ 05/27/2022 - 05/26/2026 MPI: Lipinski (contact)/Komaromy (MSU) |
|
National Eye Institute Research Project Grant (R01EY027767) ‘Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy’ 09/30/2018 – 08/31/2023 PI: Lipinski |
|
National Eye Institute Audacious Goals Initiative (U24EY029891) ‘Developing Cone-Dominant retinal disease models as a resource for translations vision research’ 09/30/2018 – 08/31/2023 MPI: Carroll/Duncan Role: Co-investigator |
|
Philanthropic Support |
Completed Grant Support for the Ocular Gene Therapy Laboratory
McPherson Eye Research Institute Vision Science Trainee Grant ‘Utilizing laser speckle contrast imaging to detect pre-clinical markers of retinal vascular dysfunction in diabetic rat models’ 09/01/2017 - 08/31/2018 PI: Patel (Mentor: Lipinski) |
|
Foundation Fighting Blindness Program Project Award (PPA-0617-0718-UCSF) ‘Characterization of Existing and Newly Development Models of Usher Syndrome’ 06/01/2017 – 05/31/2022 MPI: Duncan/Carroll Role: Co-investigator |
|
Foundation Fighting Blindness Individual Investigator Award (TA-NMT-0618-0739-MCW) ‘Maintaining Proteostasis to Prevent Photoreceptor Degeneration in Retinal Disease’ 06/01/2018 – 05/31/2021 Role: PI |
|
Glaucoma Research Foundation Shaffer Award ‘Development of rAAV Technologies to Facilitate Topical Gene Delivery to the Cornea’ 03/05/2019 – 03/04/2020 PI: Lipinski |
|
Juvenile Diabetes Research Foundation Innovative Grant (1-PNF-20140120-A-N) ‘Validation of Novel AAV vector for Target Gene Therapy to Prevent Vascular Complications of Diabetic Retinopathy’ 05/01/2014 – 10/31/2015 PI: Lipinski |